scholarly article | Q13442814 |
P50 | author | Javier Rangel-Moreno | Q37372961 |
P2093 | author name string | G G Guerrero | |
Ó Rojas-Espinosa | |||
S Islas-Trujillo | |||
P2860 | cites work | Molecular characterization of the mycobacterial heparin-binding hemagglutinin, a mycobacterial adhesin | Q28486660 |
Nitric oxide and macrophage function | Q29615327 | ||
Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages | Q29617356 | ||
TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. | Q30375496 | ||
Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy | Q30531768 | ||
How does Mycobacterium leprae target the peripheral nervous system? | Q33818891 | ||
Natural adjuvants: endogenous activators of dendritic cells | Q33878894 | ||
Leprosy lipid provides the key to Schwann cell entry | Q34137960 | ||
Leprosy bacillus--possibly the first chemoautotrophic human pathogen cultivated in vitro and characterised | Q34554703 | ||
IFNs and STATs in innate immunity to microorganisms | Q34647015 | ||
Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens | Q34657537 | ||
Dendritic cells and immunity to Listeria: TipDCs are a new recruit | Q35810870 | ||
Adjuvant activity of interferon alpha: mechanism(s) of action. | Q50724369 | ||
IFNs and STATs in innate immunity to microorganisms | Q57174196 | ||
M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells | Q59498046 | ||
Type I interferons produced by dendritic cells promote their phenotypic and functional activation | Q61473768 | ||
Binding of 14C-labeled dopa by Mycobacterium leprae in vitro | Q67522633 | ||
Parameters of interferon action: II. Immunological effects of recombinant leukocyte interferon (IFN-alpha 2) in phase I-II trials | Q71001088 | ||
Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model | Q74334942 | ||
The effect of exogenous peroxidase on the evolution of murine leprosy | Q78668200 | ||
Expression of cyclooxygenase-2, alpha 1-acid-glycoprotein and inducible nitric oxide synthase in the developing lesions of murine leprosy | Q79556035 | ||
New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy | Q35936136 | ||
Type I interferons (alpha/beta) in immunity and autoimmunity | Q36072422 | ||
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk | Q36733068 | ||
The role of type I interferon production by dendritic cells in host defense | Q36838232 | ||
Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses | Q36842908 | ||
Type I interferon as a stimulus for cross-priming | Q37027815 | ||
Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. | Q37355847 | ||
The innate immune response in leprosy | Q37671102 | ||
New pathways of protective and pathological host defense to mycobacteria | Q38025523 | ||
Insights from animal models on the immunogenetics of leprosy: a review | Q38071240 | ||
Biomarkers for leprosy: would you prefer T (cells)? | Q38112443 | ||
Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection | Q41990768 | ||
Type I interferons regulate cytolytic activity of memory CD8(+) T cells in the lung airways during respiratory virus challenge | Q42712613 | ||
Integrated pathways for neutrophil recruitment and inflammation in leprosy | Q42930976 | ||
Leprosy: what is being "eliminated"? | Q43187062 | ||
Expression of inducible nitric oxide synthase and nitrotyrosine during the evolution of experimental pulmonary tuberculosis | Q43772784 | ||
Recognition of lipid antigens by sera of mice infected with Mycobacterium lepraemurium | Q44563252 | ||
Nitrotyrosine localization to dermal nerves in borderline leprosy. | Q44804918 | ||
IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells. | Q45871212 | ||
Palsy of the rear limbs in Mycobacterium lepraemurium-infected mice results from bone damage and not from nerve involvement | Q46524702 | ||
Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species | Q47774945 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Mycobacterium bovis | Q133447 |
P304 | page(s) | 414027 | |
P577 | publication date | 2015-09-21 | |
P1433 | published in | BioMed Research International | Q17509958 |
P1476 | title | Successive Intramuscular Boosting with IFN-Alpha Protects Mycobacterium bovis BCG-Vaccinated Mice against M. lepraemurium Infection | |
P478 | volume | 2015 |
Search more.